DVA

DaVita
NYSE

Real-time Quotes | Nasdaq Last Sale

85.12
-2.20
-2.52%
After Hours: 85.12 0 0.00% 17:43 09/21 EDT
OPEN
86.31
PREV CLOSE
87.32
HIGH
86.46
LOW
82.52
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
92.67
52 WEEK LOW
54.09
MARKET CAP
10.73B
P/E (TTM)
13.54
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
What's Driving Estimates on New Strong Buy Stocks?
Amid all the uncertainty and negativity, the clear sign that we are getting into more favorable territory is the increase in earnings estimates. Here is a quick look at what is driving some of the numbers.
Zacks · 7h ago
New Strong Buy Stocks For September 21st
New Strong Buy Stocks For September 21st
Zacks · 9h ago
DaVita HealthCare (DVA) Soars to 52-Week High, Time to Cash Out?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks · 4d ago
DaVita Announces Final Results Of Self-Tender Offer
DAVITA INC. (NYSE: DVA) ("DaVita") a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today the final results of its modified "Dutch auction
PR Newswire · 4d ago
Analyst Report: DaVita Inc.
Find the latest DaVita Inc. (DVA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance
Morningstar Research · 5d ago
DaVita Announces Preliminary Results of Self-Tender Offer
DAVITA INC. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today the preliminary results of its modified "Dutch
PR Newswire · 6d ago
Hedge Funds Arent Crazy About DaVita Inc (DVA) Anymore
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). We reversed our stance on March 25th after seeing unprecedented fiscal and monetary stimulus unleashed by the Fed and the Congress
Insider Monkey · 09/10 15:11
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.
Zacks · 09/09 13:33
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 12 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DVA stock price target is 97.80 with a high estimate of 105.00 and a low estimate of 89.00.
EPS
Institutional Holdings
Institutions: 453
Institutional Holdings: 159.27M
% Owned: 126.37%
Shares Outstanding: 126.04M
TypeInstitutionsShares
Increased
128
13.76M
New
36
1.77M
Decreased
165
9.27M
Sold Out
68
4.84M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-2.06%
Healthcare Providers & Services
-2.69%
Key Executives
Chairman/Independent Director
Pamela Arway
Chief Executive Officer/Director
Javier Rodriguez
Chief Financial Officer/Treasurer
Joel Ackerman
Chief Accounting Officer
John Winstel
Chief Compliance Officer
James Hearty
Vice President
LeAnne Zumwalt
Other
Kenny Gardner
Other
Kathleen Waters
Director
Charles Berg
Director
Shawn Guertin
Independent Director
Barbara Desoer
Independent Director
Pascal Desroches
Independent Director
Paul Diaz
Independent Director
John Nehra
Independent Director
Paula Price
Independent Director
Phyllis Yale
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average DVA stock price target is 97.80 with a high estimate of 105.00 and a low estimate of 89.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About DVA
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Davita Inc stock information, including NYSE:DVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DVA stock methods without spending real money on the virtual paper trading platform.